Butterfly SPAC Presentation Deck
Investment Case Summary
A unique investment in a dynamic Med-Tech environment
Our investment case is clear:
Butterfly attacks a large, $8 billion addressable market and expands it materially by meaningfully growing each
of the following: points of care, geographic reach and use cases
Butterfly has a very clear right to win. Butterfly is the best product, the best price, and the best platform
Butterfly has many attractive investment attributes: strong balance sheet and liquidity, low manufacturing costs,
rapid growth, high recurring revenue, a discounted relative valuation and high-return reinvestment
opportunities
●
●
●
●
Finally, Butterfly has strong alignment, building clinical and societal value designed for commercial success and
shareholder value creation
9View entire presentation